Sucralfate
CAS 54182-58-0
Sucralfate (CAS 54182-58-0) is a pharmaceutical compound with 1 bioactivity target and 2,390 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| Pepsin A-5 Enzyme |
INHIBITOR | - | - | Homo sapiens |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Vaginal flatulence | 55 | 139.245 | 10064227 |
| Female genital tract fistula | 60 | 112.179 | 10061149 |
| Proctitis | 61 | 109.256 | 10036774 |
| Vaginal discharge | 58 | 96.349 | 10046901 |
| Drug ineffective | 392 | 95.862 | 10013709 |
| Angina bullosa haemorrhagica | 24 | 95.537 | 10064223 |
| Contraindicated product administered | 9 | 93.116 | 10078504 |
| Radiculopathy | 61 | 91.705 | 10037779 |
| Maternal exposure during pregnancy | 7 | 86.186 | 10071408 |
| Abdominal pain | 433 | 84.236 | 10000081 |
| Frequent bowel movements | 91 | 77.759 | 10017367 |
| Nausea | 881 | 77.253 | 10028813 |
| Oesophagitis | 80 | 76.061 | 10030216 |
| Toxicity to various agents | 65 | 74.579 | 10070863 |
| Early satiety | 30 | 73.328 | 10059186 |
| Gastritis | 111 | 71.973 | 10017853 |
| Gastrointestinal haemorrhage | 209 | 71.968 | 10017955 |
| Hand deformity | 3 | 71.857 | 10061194 |
| Vulval disorder | 24 | 71.643 | 10047754 |
| Facial asymmetry | 26 | 71.452 | 10068737 |
| Muscle swelling | 24 | 71.181 | 10064470 |
| Oral candidiasis | 82 | 66.624 | 10030963 |
| Gastrooesophageal reflux disease | 174 | 64.842 | 10017885 |
| Cholecystitis chronic | 47 | 62.443 | 10008617 |
| Joint swelling | 60 | 61.365 | 10023232 |
| Constipation | 332 | 59.35 | 10010774 |
| Systemic lupus erythematosus | 19 | 57.92 | 10042945 |
| Glossodynia | 13 | 56.115 | 10018388 |
| Pericarditis | 5 | 55.17 | 10034484 |
| Treatment failure | 30 | 53.33 | 10066901 |
| Completed suicide | 24 | 51.786 | 10010144 |
| Abdominal pain upper | 266 | 51.66 | 10000087 |
| Gastric ulcer | 76 | 49.401 | 10017822 |
| Off label use | 364 | 45.83 | 10053762 |
| Colitis ulcerative | 77 | 45.363 | 10009900 |
| Dehydration | 264 | 45.122 | 10012174 |
| Drug intolerance | 74 | 43.012 | 10061822 |
| Blood aluminium increased | 7 | 42.95 | 10005321 |
| Product use issue | 50 | 42.933 | 10076309 |
| Impaired gastric emptying | 42 | 42.381 | 10021518 |
| Exposure during pregnancy | 16 | 41.89 | 10073513 |
| Vomiting | 572 | 41.014 | 10047700 |
| Colitis | 109 | 38.847 | 10009887 |
| Haemoglobin decreased | 232 | 38.103 | 10018884 |
| Cholelithiasis | 89 | 37.597 | 10008629 |
| Wound | 23 | 36.445 | 10052428 |
| Rheumatoid arthritis | 56 | 36.396 | 10039073 |
| Liver abscess | 29 | 36.393 | 10024652 |
| Weight decreased | 352 | 35.31 | 10047895 |
| Drug abuse | 18 | 34.345 | 10013654 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Sucralfate | 10156 | SU | MTHSPL |
| SUCRALFATE | 10156 | SU | MTHSPL |
| sucralfate | 10156 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sucralfate used for in pharmaceutical contexts?
Sucralfate (CAS 54182-58-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sucralfate?
Sucralfate has 2,390 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Vaginal flatulence, Female genital tract fistula, Proctitis, Vaginal discharge, Drug ineffective. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sucralfate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Aluminum Sucrose Octasulfate with EU status "permitted".
What clinical phase is Sucralfate in?
No phase 1-4 clinical development badge is rendered for Sucralfate because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Sucralfate?
Sucralfate has 1 bioactivity row in this page query. Rendered target entries include Pepsin A-5.